UltiMalVax's endeavour to develop a vaccine for malaria elimination is on track
Project partners and members of SEAC met in Portugal to discuss progress, challenges and upcoming activities.
top of page
Search
Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Health and Digital Executive Agency. Neither the European Union nor the granting authority can be held responsible for them.
University of Oxford –Project number: 10079577; NeoVac LTD – Project number 10079247; SpyBiotech LTD - project number 10115196
Vaccine Formulation Institute - The grant number is REF-1131-52304 / SERI No. 23.00184.
NEWSLETTER
© 2024 by European Vaccine Initiative
bottom of page